--- title: House Agriculture & Consumer Affairs Committee, March 24, 2026 collection: meetings id: 2026-03-24/house-agriculture-and-consumer-affairs cite_as: House Agriculture & Consumer Affairs Committee, March 24, 2026, video https://vimeo.com/1176582204 (machine transcript by Georgia Commons) canonical_url: https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs md_url: https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs.md text_url: https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs/text source_url: https://vimeo.com/1176582204 date: 2026-03-24 status: machine transcript corpus_version: meetings-2026-10-23-8c15ead0f18d license: Machine transcript and summaries by Georgia Commons from the General Assembly's public video; the video stays on the General Assembly's Vimeo channel; see about.md publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice. up: https://georgiacommons.org/meetings/2026-03-24.md previous: https://georgiacommons.org/meetings/2026-03-24/house-motor-vehicles.md next: https://georgiacommons.org/meetings/2026-03-24/senate-state-and-local-governmental-operations.md index: https://georgiacommons.org/meetings/index.md chamber: House body: House Agriculture & Consumer Affairs Committee body_url: https://georgiacommons.org/meetings/house-agriculture-and-consumer-affairs.md meeting_kind: committee session: 2025-2026 Regular Session start_time: 2026-03-24T11:00:00-04:00 location: 606 CLOB duration_seconds: 4726.0 video_id: 1176582204 video_title: 03.24.26 Agriculture and Consumer Affairs agenda_url: https://www.legis.ga.gov/api/document/agendas/house/Agriculture%2FAG & CA Meeting Notice- Tuesday, 3-24-26.pdf bills_discussed: - SB 33 summaries_model: gpt-6.1-sol transcript_turns: 435 transcript_chars: 73220 parts: - https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs.md?start=0 - https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs.md?start=59957 --- # House Agriculture & Consumer Affairs Committee, March 24, 2026 House Agriculture & Consumer Affairs Committee; March 24, 2026; 2025-2026 Regular Session. Video, on the General Assembly's Vimeo channel: https://vimeo.com/1176582204. Agenda: https://www.legis.ga.gov/api/document/agendas/house/Agriculture%2FAG & CA Meeting Notice- Tuesday, 3-24-26.pdf. > This is a machine transcript of the General Assembly's video, made by a speech-recognition model. It is not an official record and can mishear words, names, and numbers. Speakers are not identified. The video is the record: every timestamp links to the moment it plays. ## Summary written by Georgia Commons Written by gpt-6.1-sol from the transcript below. It is not part of the record. Quote the transcript or the video, not the summary. The committee considered two versions of [SB 33](https://georgiacommons.org/bills/2025-2026/sb33) addressing hemp-derived products. The sponsor presented a version intended to align Georgia law with federal limits on intoxicating cannabinoids. Members raised concerns about federal timing, enforcement, businesses and consumers who use the products. The chair then presented a narrower substitute targeting cannabinoids that cannot occur naturally in the cannabis plant. After adding a definition of products containing those cannabinoids and related references, the committee unanimously recommended passage of the substitute as amended. ## Bills discussed (1) Each account was written by gpt-6.1-sol from the stretch of the transcript it names. The bill's number is said in that stretch, unless it was the only bill on a committee's agenda. ### SB 33. "Georgia Hemp Farming Act"; total THC concentration of consumable hemp products; provide limits [SB 33](https://georgiacommons.org/bills/2025-2026/sb33) (2025-2026 Regular Session). From [0:18:23](https://vimeo.com/1176582204#t=1103s), turns 82 to 431. The sponsor said [SB 33](https://georgiacommons.org/bills/2025-2026/sb33) would protect consumers from intoxicating cannabinoids lacking safeguards applied to Delta-9. The sponsor’s version would follow federal limits of 0.3% by dry weight and 0.4 milligrams per container, cover vapes above the limit, authorize destruction of noncompliant products and take effect January 1, 2027. The sponsor said federal enforcement was scheduled for November 12, 2026. Members questioned federal timing and state enforcement authority, and reported concerns from businesses and families about lost access to products. The sponsor cited injuries and children requiring intensive care as reasons to act. The chair offered a narrower substitute. A Department of Agriculture representative said it would restrict cannabinoids incapable of occurring naturally in the cannabis plant, add drug penalties and expand seizure authority, while leaving existing Delta-9 limits unchanged. The representative clarified that Delta-8 would not be covered, even when made synthetically, and said federal implementation might be delayed. Asked about enforcement costs, the representative had no estimate and said the department needed more support. The representative also explained existing package labeling and testing requirements for hemp vapes. After a member questioned an undefined term, the committee adopted an amendment defining products containing synthetic cannabinoids and adding related references. The committee then unanimously recommended passage of the substitute as amended. > The transcript runs 73,220 characters. A reader that cannot take it at once can read it in 2 parts: part 1 https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs.md?start=0; part 2 https://georgiacommons.org/meetings/2026-03-24/house-agriculture-and-consumer-affairs.md?start=59957. ## Transcript (435 turns) [0:00:03](https://vimeo.com/1176582204#t=3s) So she agreed to a call, um, so we were really excited. So [0:00:15](https://vimeo.com/1176582204#t=15s) she was completely open, really, really nice. She's talked to whoever she could this morning. So- [0:00:20](https://vimeo.com/1176582204#t=20s) Well, it's a big treasure. [0:00:21](https://vimeo.com/1176582204#t=21s) Yeah, and we have over here that you have five hundred emails. I know, I'm sorry. [0:00:27](https://vimeo.com/1176582204#t=27s) Well, they've gotten better. Hold on, let me put this down. [0:00:32](https://vimeo.com/1176582204#t=32s) Are you with the head office? [0:00:33](https://vimeo.com/1176582204#t=33s) Oh, my goodness. You're sorry. [0:00:35](https://vimeo.com/1176582204#t=35s) Uh, I am. My name is Lynn Simon and I'm just talking to him. Um, I am a CBD store too. [0:00:41](https://vimeo.com/1176582204#t=41s) Uh-huh. Yes. The CBD home? Oh, God. [0:00:44](https://vimeo.com/1176582204#t=44s) Just to let you know, we did just speak to- [0:00:48](https://vimeo.com/1176582204#t=48s) Yeah. [0:00:49](https://vimeo.com/1176582204#t=49s) And she asked if we could work out. [0:00:49](https://vimeo.com/1176582204#t=49s) As it says, "In addition to Ms. John, we have received confirmation that Bailey talks about CBD." [0:00:58](https://vimeo.com/1176582204#t=58s) Um, I wanted to make sure that you don't feel weird about giving me that. [0:01:01](https://vimeo.com/1176582204#t=61s) So, I-- So all I know is, um, I was approached by an office with the Georgia Association of Defense Lawyers. Um, I had testified before on other bills, not in this particular context. The prior year, I think it was this year. Is that it? [0:01:20](https://vimeo.com/1176582204#t=80s) That was the last one. [0:01:21](https://vimeo.com/1176582204#t=81s) Where is it? [0:01:22](https://vimeo.com/1176582204#t=82s) Um, it's on sixteen. [0:01:24](https://vimeo.com/1176582204#t=84s) Nada. [0:01:25](https://vimeo.com/1176582204#t=85s) No. They just built the [0:01:27](https://vimeo.com/1176582204#t=87s) I'm not the guy, so I'm not... So, I mean, I'm not, uh, I'm not a lobbyist. I'm not a lobbyist, so I don't know a lot of the lobbyist that are in the house. I simply came over here. I am no part, part-- As a lawyer, I'm kind of involved in not so much the consumer health side of it. [0:01:42](https://vimeo.com/1176582204#t=102s) Yeah. [0:01:45](https://vimeo.com/1176582204#t=105s) Well, and, and part of, you know, my focus is that if somebody was bringing those kinds of cases and what this bill is saying, that just any of the current- [0:01:53](https://vimeo.com/1176582204#t=113s) I don't know. [0:01:55](https://vimeo.com/1176582204#t=115s) Consumer-- Some consumers. [0:01:58](https://vimeo.com/1176582204#t=118s) So last week, she was going through [0:02:01](https://vimeo.com/1176582204#t=121s) this whole thing. There was... No. She will be delivering it again. So she did it the twenty-third. So again, on the first. [0:02:10](https://vimeo.com/1176582204#t=130s) And we gotta be careful. [0:02:11](https://vimeo.com/1176582204#t=131s) I know. We were talking to Tom. [0:02:13](https://vimeo.com/1176582204#t=133s) Yeah. [0:02:14](https://vimeo.com/1176582204#t=134s) This might actually be still. That's still up to you. [0:02:17](https://vimeo.com/1176582204#t=137s) Yeah. I hear you. That, that, that's not-- This, this battle is much bigger than just THC. [0:02:23](https://vimeo.com/1176582204#t=143s) Yeah. [0:02:23](https://vimeo.com/1176582204#t=143s) It's easier. [0:02:25](https://vimeo.com/1176582204#t=145s) So yeah, yeah, sure. So basically, um... [0:02:29](https://vimeo.com/1176582204#t=149s) I mean, this is really, really, um... [0:02:34](https://vimeo.com/1176582204#t=154s) I'll hear. [0:02:36](https://vimeo.com/1176582204#t=156s) I'm not gonna fly anywhere like that. It's no good. Awesome. Thank you so much. [0:02:47](https://vimeo.com/1176582204#t=167s) Can I get you to... Oh. [0:02:50](https://vimeo.com/1176582204#t=170s) Yeah. [0:02:55](https://vimeo.com/1176582204#t=175s) But they, they want the... [0:02:56](https://vimeo.com/1176582204#t=176s) I hear you. But this is not gonna... My, my point is we gotta address this and I don't think that- That's what. Fine. Right. [0:03:05](https://vimeo.com/1176582204#t=185s) So, um... [0:03:06](https://vimeo.com/1176582204#t=186s) I'm not. I don't think you guys know. You guys know this. [0:03:13](https://vimeo.com/1176582204#t=193s) Yeah. [0:03:16](https://vimeo.com/1176582204#t=196s) Well, this is gonna be a real get. I mean, this is really important. This is just the opening. [0:03:23](https://vimeo.com/1176582204#t=203s) Mm-hmm. [0:03:42](https://vimeo.com/1176582204#t=222s) You have a medical, uh, card for us? We'll see what happens. [0:03:46](https://vimeo.com/1176582204#t=226s) I still have hope. [0:03:47](https://vimeo.com/1176582204#t=227s) Really good luck. [0:03:48](https://vimeo.com/1176582204#t=228s) We'll see. [0:04:07](https://vimeo.com/1176582204#t=247s) It's okay if we sit on this row? [0:04:08](https://vimeo.com/1176582204#t=248s) Of course. Like I said, Angie was gonna bring in a couple- [0:04:11](https://vimeo.com/1176582204#t=251s) Sure, yeah [0:04:12](https://vimeo.com/1176582204#t=252s) ... of your gentlemen last time, but... [0:04:18](https://vimeo.com/1176582204#t=258s) Well, let's eat them. So are they gonna hear this bill at all today? [0:04:33](https://vimeo.com/1176582204#t=273s) Some of them. [0:04:35](https://vimeo.com/1176582204#t=275s) Well, we got some for... [0:04:40](https://vimeo.com/1176582204#t=280s) It's a process. Not even half [0:04:51](https://vimeo.com/1176582204#t=291s) present? [0:04:52](https://vimeo.com/1176582204#t=292s) No. [0:04:52](https://vimeo.com/1176582204#t=292s) Okay. [0:04:52](https://vimeo.com/1176582204#t=292s) I appreciate all the last minute- [0:04:53](https://vimeo.com/1176582204#t=293s) Well, gross is showing high, high interest. [0:04:58](https://vimeo.com/1176582204#t=298s) Thanks for your time. [0:05:00](https://vimeo.com/1176582204#t=300s) Thanks for having me. [0:05:03](https://vimeo.com/1176582204#t=303s) That's why I'm a lawyer, not a lobbyist. [0:05:05](https://vimeo.com/1176582204#t=305s) Oh, I know. Trust me. That's... [0:05:25](https://vimeo.com/1176582204#t=325s) So, okay. But I'm happy to. [0:05:32](https://vimeo.com/1176582204#t=332s) It sounds like- [0:05:32](https://vimeo.com/1176582204#t=332s) You should go out. You guys should. [0:05:32](https://vimeo.com/1176582204#t=332s) Good to see you. [0:05:33](https://vimeo.com/1176582204#t=333s) Hi. [0:05:34](https://vimeo.com/1176582204#t=334s) How are you? Good to see you. [0:05:36](https://vimeo.com/1176582204#t=336s) You too. [0:05:40](https://vimeo.com/1176582204#t=340s) Jeannie. [0:05:41](https://vimeo.com/1176582204#t=341s) Hey. [0:05:43](https://vimeo.com/1176582204#t=343s) That's my wife there. [0:05:45](https://vimeo.com/1176582204#t=345s) That's right. [0:05:46](https://vimeo.com/1176582204#t=346s) Yeah. Your seat's great. Your seat's great. Thanks for seeing me. Absolutely. Chrissy? [0:05:54](https://vimeo.com/1176582204#t=354s) Table just right now, so. [0:05:55](https://vimeo.com/1176582204#t=355s) Just wondering what- [0:17:44](https://vimeo.com/1176582204#t=1064s) Well, good morning. Uh, welcome to, uh, House Committee Day. I apologize for a little late. I was trying to, uh, do a little farming, uh, back at home. We do have a peach crop, although not a bumper crop of early fruit, but we do have, uh, some great sweet Georgia peaches coming, I hope. And so I can't wait to get back to Musella to, uh, start working on that. Uh, so thank y'all for being here. We got a great big, huge group this morning, and, uh, looking forward to a little discussion, um, this morning on, uh, SB33. [0:18:24](https://vimeo.com/1176582204#t=1104s) So I'm gonna ask, uh, Vice Chair, um, Joe Campbell to lead us up in a, uh, in a prayer. You 21. [0:18:35](https://vimeo.com/1176582204#t=1115s) Father, we just come to you with thanks, and thank you for this day. Thank you for the opportunity that, that we've been given to, uh, to do your work with the, with the state, with the people, and we just lift that up, and we pray that we follow you in all that we do, and, uh, seek you and seek your wisdom. Thank you for that in Jesus' name. Amen. [0:18:55](https://vimeo.com/1176582204#t=1135s) Amen. [0:18:57](https://vimeo.com/1176582204#t=1137s) Thank you. So, um, let me c- catch the committee up, um, a little bit on where we are. Um, Senator Kirkpatrick, uh, thank you for being here, Senator. She's here, and she, uh, uh, the Senate sent us SB33 over last year. Come on, sit at the front table. Uh, sent us over, um, SB33 last year, which I think we heard, and, uh, we heard it again, and I think we've heard several versions of this, and I just wanna thank you for all the work you put into this and effort and, uh, uh, as well as Paul Higby, our, uh, legal counsel, and other interested, uh, people, uh, as well as Department of Ag, Catherine Russell, and others. [0:19:43](https://vimeo.com/1176582204#t=1183s) So, um, in your packet, uh, you have, Senator Kirkpatrick's gonna present her bill that she's worked on, uh, LC 443468S. And, um, I wanted her, this is, uh, uh, her sub with some changes from the original bill that came over, and I want her to explain a little bit, um, what her bill does. And, um, and I, so I'll just turn it over, uh, to you, Senator. [0:20:17](https://vimeo.com/1176582204#t=1217s) Thank you. Yep, you got it. [0:20:20](https://vimeo.com/1176582204#t=1220s) It's a great day to be a Georgian. Um, you guys have heard this bill before several times, and this is one of the many substitute bills that Chairman Dickey and I have worked on with the Department of Agriculture, and, um, uh, I think he's got a different idea at this point. And so I'm just gonna go through this and explain what it does, just to refresh your memory briefly, 'cause I know it's been very confusing for the committee. [0:20:49](https://vimeo.com/1176582204#t=1249s) It, it has been, and I just wanna tell the committee how m- how hard you've worked on this, and it's, it's a lot to get our hands around. And, um, and, uh, but you're, um, you know, we do, we do have another c- uh, substitute coming behind, but yours has a lot of merit. I, I just wanna thank you for your effort on this and for, um, your commitment to, to, to do something, uh, with these, uh, with these products. So I hope you'll, um, pay attention, uh, this morning. [0:21:19](https://vimeo.com/1176582204#t=1279s) Thank you, Mr. Chair, and I do have another committee meeting at 11:30, so I won't be here when you vote very likely. But anyway, thanks for the, uh- [0:21:28](https://vimeo.com/1176582204#t=1288s) Uh, let me tell the committee, uh, the LC number is LC443468S. That's the, that's the one, uh, with how many pages? 14 pages. [0:21:42](https://vimeo.com/1176582204#t=1302s) One hundred. [0:21:44](https://vimeo.com/1176582204#t=1304s) Okay. [0:21:45](https://vimeo.com/1176582204#t=1305s) Okay. My intent all along has been to protect the public from unreg- regulated cannabinoids that are being sold in retail outlets without the same safeguards that we have in place for Delta-9, and these are things like Delta-8, Delta-10, and many synthetics like HHC. There are dozens of these products. The bill changed this session from last year. We didn't end up voting the bill out of this committee last year because it got very science-y, and we were running out of time. [0:22:19](https://vimeo.com/1176582204#t=1339s) So in the meantime, the federal government prohibited intoxicating cannabinoids like the ones we're talking about above 0.3% by dry weight and above 0.4 milligrams per container. This was passed in the Continuing Appropriations Act, which was signed November 12th of 2025. Enforcement is scheduled to begin in November of this year, November 12th, 2026. [0:22:50](https://vimeo.com/1176582204#t=1370s) Delta-8 and many other cannabinoids exist in trace amounts in the plant, but not at a level that would be intoxicating without chemical enhancement. So what a lot of these products are have a little bit of the product from the plant, but then they're treated with a chemical process to make them stronger. CBD products fall under the lower level, so they're not really involved with this conversation. This bill does several things. It tracks the federal language so that our state law enforcement can enforce the limits. [0:23:25](https://vimeo.com/1176582204#t=1405s) It allows for the destruction of non-compliant products, and the one thing that doesn't go along with the federal bill, I added vapes if they're above the limit. It also instructs the department to promulgate rules within 90 days of the federal rules being released, and the effective date of the bill is January 1st of 2027. [0:23:47](https://vimeo.com/1176582204#t=1427s) Understand there have been some concerns from the department about their ability to enforce and, uh, test and so on. And so, um, there is a substitute that the chairman will present, and I'll turn it over to him. [0:24:03](https://vimeo.com/1176582204#t=1443s) Um, thank you, um, Senator. Um, are there any questions, um, from the Senator on, on, um, on her bill? Now is the time. I think she did a pretty good job of, uh- [0:24:17](https://vimeo.com/1176582204#t=1457s) Yes, sir [0:24:17](https://vimeo.com/1176582204#t=1457s) ... of, uh, explaining where we are. Um, Representative Reese. [0:24:22](https://vimeo.com/1176582204#t=1462s) Thank you, Mr. Chairman. Uh, and thank you, Senator, for your, Chairwoman, for your, uh, presenting this bill. Just a, a question of clarity because we have talked about this so much and things are beginning to run together. Um, uh, I think one of my colleagues here last meeting talked about the enforcement of the federal act as if we were not sure if it was actually about to go into effect, and that colleague very wisely said that we may want to wait because we don't want to do something that may be outside of federal compliance, and then we gotta come back in and rush and redo it. [0:24:57](https://vimeo.com/1176582204#t=1497s) And I think it was this wise lady right here , my colleague, uh, Representative Camp. Can you just clarify that for me? Because right now things are kind of running together, and I, I just want to make sure I'm in the right mind frame. [0:25:07](https://vimeo.com/1176582204#t=1507s) Sure. Um, the bill is currently in effect, and enforcement is scheduled to start in November, as I said. There are some attempts to, um, delay the effective date, and, um, there's also one bill to try to repeal the amendments. My understanding is that, uh, n- none of those are actively moving forward at this time, so I think we have to be ready as a state to enforce the law if it stays in effect in November, and we won't be back here till January. [0:25:48](https://vimeo.com/1176582204#t=1548s) Any other questions of the senator? My, my committee's mighty quiet. No, here they go. Here they go. Representative Carter. [0:25:59](https://vimeo.com/1176582204#t=1559s) Thank you, Chairman. Uh, Senator, um, I guess my question, kind of the same lines of my colleague here, can you show me specifically, 'cause I understand there's some language that, uh, we'll address was the federal government that we know they've already passed, and then there are some things in here that are subject to. Can you just walk us through the specifics of what would bring us currently in compliance and what is future planned based on some evidence? [0:26:30](https://vimeo.com/1176582204#t=1590s) Well, right now there's, right now there's, um, at the state level, uh, no limits in place for anything alter- other than Delta-9. So in other words, Delta-8, Delta-10, all that's completely unregulated. [0:26:44](https://vimeo.com/1176582204#t=1604s) Okay, I'm referring to your bill. So- [0:26:46](https://vimeo.com/1176582204#t=1606s) Right [0:26:46](https://vimeo.com/1176582204#t=1606s) ... so there's some, some language in your bill that- [0:26:49](https://vimeo.com/1176582204#t=1609s) Yes, pretty much- [0:26:49](https://vimeo.com/1176582204#t=1609s) ... is currently in line, as you said, with the federal government, and then there was some- something that you s- you said that was subject to a date change. [0:26:58](https://vimeo.com/1176582204#t=1618s) Yeah, the- [0:26:58](https://vimeo.com/1176582204#t=1618s) Can you please just walk us specifically through that? [0:27:00](https://vimeo.com/1176582204#t=1620s) Everything in the bill is in line with the federal law, except that I added language about vaping, which is, um, I'll have to find the line number. [0:27:11](https://vimeo.com/1176582204#t=1631s) Okay. [0:27:11](https://vimeo.com/1176582204#t=1631s) But everything else, it, it, it all comes back to the .3% by dry weight and the .4 milligrams per container. That's the federal law, and that's what's in the bill. [0:27:24](https://vimeo.com/1176582204#t=1644s) Okay, you just made some references, so you're saying the only thing that is a federal law that's in here is the vaping, so we just need to find the language for the vaping. But everything else in this bill- [0:27:33](https://vimeo.com/1176582204#t=1653s) That's, uh- [0:27:33](https://vimeo.com/1176582204#t=1653s) ... you're saying aligns with federal law. [0:27:35](https://vimeo.com/1176582204#t=1655s) That's ... Yeah, it's, uh, line 140, 141. And did you find that one other spot? [0:27:42](https://vimeo.com/1176582204#t=1662s) That's where smoking is and the prohibition- [0:27:43](https://vimeo.com/1176582204#t=1663s) Yeah [0:27:44](https://vimeo.com/1176582204#t=1664s) ... is in section 160. [0:27:50](https://vimeo.com/1176582204#t=1670s) Yeah. [0:28:08](https://vimeo.com/1176582204#t=1688s) There's a 14 [0:28:08](https://vimeo.com/1176582204#t=1688s) Oh, yeah, that's in line 226. [0:28:12](https://vimeo.com/1176582204#t=1692s) So your bill als- uh, really, it, uh, uh, st- is doing away with a, a vast variety of intoxicating cannabinoids. [0:28:22](https://vimeo.com/1176582204#t=1702s) Exactly. [0:28:22](https://vimeo.com/1176582204#t=1702s) All of them, uh, really. [0:28:24](https://vimeo.com/1176582204#t=1704s) Right. [0:28:25](https://vimeo.com/1176582204#t=1705s) Yeah. Representative Wil- uh, Representative Willis. [0:28:30](https://vimeo.com/1176582204#t=1710s) Thank you, Mr. Chairman. Good morning. Um, and thank you for your diligence. So dovetailing off what the chairman just asked, I'm noticing that the amended language, we've taken out Delta-9 because Delta-9 now has regulations, correct? [0:28:47](https://vimeo.com/1176582204#t=1727s) Correct. It, it just strikes Delta-9. Every place that says Delta-9, now it says THC. [0:28:52](https://vimeo.com/1176582204#t=1732s) And THCA in some parts- [0:28:55](https://vimeo.com/1176582204#t=1735s) Yes [0:28:55](https://vimeo.com/1176582204#t=1735s) ... right? Which, and I know that there are a multitude of cannabinoids outside of Delta-9 because hemp is so vast. So Delta-9 has its regulations. This is just a, a drill-down p- pedestrian language about it just for comprehension. Delta-9 has its regulations. Your intent is to bring regulations around the other intoxicating cannabinoids that are at .3 or above percent, right? [0:29:22](https://vimeo.com/1176582204#t=1762s) Correct. [0:29:23](https://vimeo.com/1176582204#t=1763s) Okay. And so .3, per my comprehension, .3 has been, like, the, the, the baseline amount that you could have of cannabinoids and nothing above it. So is what you're saying that these other cannabinoids that aren't Delta-9 don't have that .3 regulation and that's what you're seeking? And then you added the vape language, which would then what? What exactly does that vape language do? Does it mean anything above .3% in a vape? [0:29:52](https://vimeo.com/1176582204#t=1792s) Yes. [0:29:53](https://vimeo.com/1176582204#t=1793s) Okay. [0:29:56](https://vimeo.com/1176582204#t=1796s) And do the vapes, 'cause vaping is a real, I've been get- I've gotten, I counted, 323 emails- [0:30:03](https://vimeo.com/1176582204#t=1803s) I'm up to almost 2,000 [0:30:04](https://vimeo.com/1176582204#t=1804s) ... about this bill in a week. And so, um- [0:30:07](https://vimeo.com/1176582204#t=1807s) Sorry about that. [0:30:08](https://vimeo.com/1176582204#t=1808s) No, no, no. No, but that lets me know. B- but what that does le- and it's 2,000 overall, but what it does let me know is this is of real concern. This is, this is impacting farmers. This is impacting, um, hemp processors, which we don't have enough of in the state as it is. Um, and so it, it le- I just wanted to know if everybody else was getting that volume- [0:30:29](https://vimeo.com/1176582204#t=1829s) Yeah [0:30:29](https://vimeo.com/1176582204#t=1829s) ... of feedback about the issue. But it also lets me know, as I'm hearing from farmers and processors, specifically I'm hearing more from processors, that this places a great hindrance potentially on their business. So I'm just trying to understand all of the different sides. Have you considered pulling the, making the vaping a specific issue? Because I think that is something that people have a great concern about, even as they don't have full understanding of all of these things. It was just a suggestion and something I heard from my constituents, so I just wanted to go on the record for bringing that to you today. [0:31:02](https://vimeo.com/1176582204#t=1862s) Thank you, Chair. [0:31:02](https://vimeo.com/1176582204#t=1862s) Sure, I'd be happy to do that, but that would have to be a different bill next year. A little late this year. [0:31:08](https://vimeo.com/1176582204#t=1868s) Well, how do we do this as far as voting on it? [0:31:09](https://vimeo.com/1176582204#t=1869s) Okay. All right. Let's, uh, and then- [0:31:11](https://vimeo.com/1176582204#t=1871s) Well, I would say that unless some of the legislative efforts at the federal level are successful, this bill is going to start being enforced November 12th of this year. And so I think our, uh, state regulators are gonna have to figure this out, and, uh, might as well go ahead and figure it out now, because it's gonna be effective. It's already effective, and the enforcement's rolling around in just a few months. [0:31:45](https://vimeo.com/1176582204#t=1905s) Representative Stinson. [0:31:46](https://vimeo.com/1176582204#t=1906s) Federal level. [0:31:49](https://vimeo.com/1176582204#t=1909s) Thank you, Mr. Chairman. Um, my comment is kind of in line with my colleague, uh, Representative Willis. Uh, Senator, thank you for your work on this. And last evening, I had a chance to speak with several families, um, that shared with me their stories and how, um, this legislation is really going to, um, hinder their quality of life. And so basically, um, as Representative Willis stated, um, all the emails that we received. And so, um, I just, just want to be on record that I addressed, uh, my concerns that, uh, th- this bill, from what I'm hearing from the families that I spoke with last night, is gonna really hinder their quality of life. [0:32:31](https://vimeo.com/1176582204#t=1951s) So thank you. Just wanna put that out there. [0:32:34](https://vimeo.com/1176582204#t=1954s) Representative O'Steen. [0:32:36](https://vimeo.com/1176582204#t=1956s) Thank you, Mr. Chairman. I have two questions, I think. How can I tell the difference between a vape that has nicotine in it and a vape that has this stuff in it? Do they look the same? Is there something on this label that lets me know the difference between... [0:32:57](https://vimeo.com/1176582204#t=1977s) Do you know that answer? [0:32:58](https://vimeo.com/1176582204#t=1978s) There, there should be, because the product should be tested and labeled. But currently, because they're not regulated, that's not the case. [0:33:07](https://vimeo.com/1176582204#t=1987s) So I don't, I don't know the difference if somebody is vaping nicotine or vaping THC. Right. Right, so that's a problem. Um- [0:33:19](https://vimeo.com/1176582204#t=1999s) That's why we need labeling and testing of these products. [0:33:24](https://vimeo.com/1176582204#t=2004s) There was one more question that I had. Um, let, let me pass, Mr. Chairman, if it comes back around this morning, I think that I- [0:33:29](https://vimeo.com/1176582204#t=2009s) Representative Cox. [0:33:31](https://vimeo.com/1176582204#t=2011s) Yeah. Uh, thank you, Chair. Um, I guess my question would be, due to the federal laws that are in place that will be implemented at this point, I guess you said in November, correct? Okay. Um, if this bill is not passed, [0:33:51](https://vimeo.com/1176582204#t=2031s) how does that position the state of Georgia in executing what the federal law is requiring? [0:34:01](https://vimeo.com/1176582204#t=2041s) Well, currently, my understanding is that federal law enforcement would be accountable for enforcing the federal law, just like any other law that involves, uh, federal law enforcement. But for our state law enforcement to be able to follow the law, I think they'd need authority to do that. And so that's one of the things I was trying to do with this bill. But if the products are prohibited federally, they're gonna have to come out of the retail stores. [0:34:37](https://vimeo.com/1176582204#t=2077s) And so the process of how that happens is what I'm trying to put in place so that our department that's accountable for that would be able to, uh, follow federal law. [0:34:51](https://vimeo.com/1176582204#t=2091s) Okay. Follow-up, Chair? [0:34:52](https://vimeo.com/1176582204#t=2092s) Yeah. [0:34:55](https://vimeo.com/1176582204#t=2095s) S- so as I'm, as I'm thinking through this an- and hearing some of the thoughts about kind of letting this pot simmer a little bit so we understand the impact that the federal law's actually gonna have, um, the, the timeframe we're concerned about is November till we're back in session in January. Would that be correct? [0:35:15](https://vimeo.com/1176582204#t=2115s) Right. [0:35:15](https://vimeo.com/1176582204#t=2115s) That's what you put. [0:35:17](https://vimeo.com/1176582204#t=2117s) Um, that's, actually the effective date of the bill is January 1st, the idea being to give the department a little time to kind of figure out how they're gonna fit it all together. But it's up to the committee whether you wanna simmer the pot or whether you wanna go ahead and set up the framework now. [0:35:37](https://vimeo.com/1176582204#t=2137s) Okay. Thank you. [0:35:43](https://vimeo.com/1176582204#t=2143s) Mike, uh, Representative [0:35:46](https://vimeo.com/1176582204#t=2146s) Thank you, Mr. Chair. Uh, just a follow-up question, if I may. Um, Madam Senator, so is it November or January, the enforceable date? I'm hearing two dates now. [0:35:56](https://vimeo.com/1176582204#t=2156s) The federal enforcement date is November 12th- [0:35:59](https://vimeo.com/1176582204#t=2159s) Okay [0:35:59](https://vimeo.com/1176582204#t=2159s) ... of this year. [0:36:00](https://vimeo.com/1176582204#t=2160s) Okay. And then what was the January date? It was- [0:36:02](https://vimeo.com/1176582204#t=2162s) That's the effective date of the bill. [0:36:04](https://vimeo.com/1176582204#t=2164s) Effective date of the bill. Okay. So I think for me, uh, based upon the feedback, and thank you for the clarification, I have, I have ... I just wanna be, excuse me, on record. I have ... There's too much ambiguity for me between where we are, where we desire to be, what's coming from a federal level, and how this impacts the ecosystem, uh, around this, uh, for me. Because I've heard from individuals who have been, um, able to have a better quality of life because of access to certain products. [0:36:41](https://vimeo.com/1176582204#t=2201s) I've heard from, um, processors. I'm just hearing throughout the ecosystem. So for me, I, I'm, I'm unable to hear enough clarification around the issues that we've had to see what we gain from waiting a little longer to get more robust information when it's only a few months between the implementation of the federal law and our start date. But I do appreciate the edification of the bill. I'm just still uncertain. Thank you. [0:37:10](https://vimeo.com/1176582204#t=2230s) Um, Chairwoman Darlene Taylor. [0:37:12](https://vimeo.com/1176582204#t=2232s) Thank you, Mr. Chairman. Would this, if we don't pass it, is it gonna put us in any jeopardy of not being aligned with the feds? [0:37:20](https://vimeo.com/1176582204#t=2240s) Um, I'm not really sure about that. I know that other states are dealing with the same issue right now, and everyone's trying to figure it out. [0:37:30](https://vimeo.com/1176582204#t=2250s) Okay. [0:37:30](https://vimeo.com/1176582204#t=2250s) So I think there are a lot of people that are counting on the effective date being moved back, but I'm not sure at this late date that that's gonna happen, uh, because we know how, uh, functional Congress is in passing legislation. They don't operate the same way we do. Um, so I am somewhat concerned about that, but federal law enforcement would certainly already have the authority to enforce. [0:37:55](https://vimeo.com/1176582204#t=2275s) It would ... Their, their laws would supersede ours, but I wanna make sure that it does not, um ... If we don't fix this, is it gonna jeopardize ag, ag grants or law enforcement or getting us out of alignment with the federal government? That's my concern. Thank you. [0:38:12](https://vimeo.com/1176582204#t=2292s) All right. Uh, I know you have to go, and I've, um ... You've got one more. Um, so I think that's the end of our questions. Thank you for being here. Thank you again for the work on this and trying to, uh, help, uh, help our state get a handle around these products. I, I know, uh, in an effort to, uh, legalize hemp, uh, was good intentions. But with, with that, uh, and I know a lot of processors have, uh, worked around, uh, around, um, that and, and have these intoxicating, uh, products out there. [0:38:48](https://vimeo.com/1176582204#t=2328s) I think the CBD is, uh, uh, is very well received. It's the THC, I think, that you're really trying to address, uh, with a lot of this bill and, and the workaround, uh, that, um, many have done. So thank you for this. Um, I thank you f- committee for, um, for your questions and, uh, concerns. Any- anything else you'd like to say? [0:39:12](https://vimeo.com/1176582204#t=2352s) Yeah, I, I was just gonna say the, my whole reason for tackling this several years ago was because of the danger to the public that's represented by substances that are not treated in the same way, tested and labeled in the same way as our Delta-9 products. And as I said the last time I w- talked to you all, um, there are people being hurt. The FDA has sent warning letters. There are toddlers ending up in the ICU, and that is the entire reason that I tackled this. [0:39:43](https://vimeo.com/1176582204#t=2383s) I'm not trying to put anybody out of business. If their business model's in jeopardy, that is coming from the federal level at this point. And, uh, obviously, the will of the committee, you guys do what you need to do. And, um, we'll talk more later. Thank you very much. [0:39:59](https://vimeo.com/1176582204#t=2399s) Thank you. Thank you for your time. Th- thank you for your time, uh, Senator. Appreciate it very much. Okay. Um, heard that. Um, in the meantime, i- in your packet, like to, uh, present LC443559S. That's the, um, seven-page, um, committee substitute that, uh, I've worked, uh, with, um, that council and, uh, the p- Department of Ag, Catherine Russell, I think. [0:40:33](https://vimeo.com/1176582204#t=2433s) Catherine, are you here? Yeah, there you are. Um, but I'd like to, uh, take a minute to go through here. This is, uh, uh, uh, does, uh, a little less, uh, than what, um, the previous bill did. Um, and, um, and I'll let Catherine, um, a little bit more, um, expertise on, on some of this than I am. Uh, I'm, I'm not an attorney, and as y'all see, uh, a lot of this stuff can get very technical. And, uh, you wanna come to the, um ... [0:41:07](https://vimeo.com/1176582204#t=2467s) But in essence, um, big picture, which I am kind of a person, we're tackling the synthetic cannabinoids that, um, the processors really found a loophole, uh, in my opinion, uh, to get around, uh, and getting away from the, um, hemp-based products that were intended. And so this bill, uh, really tackles the synthetic commino- cannabinoids. And, um, and Section 12 also gives the commissioner, uh, some enforcement power to, um, confiscate things, uh, these products, uh, that he doesn't have now. [0:41:48](https://vimeo.com/1176582204#t=2508s) Um, by the way, the commissioner's, in my opinion, is doing a great job with the, um, regulation of all these products that are out there now. I think, uh, he's talked to this committee before about, um, his limited budget, but a great, uh, law enforcement group that are going out looking and, uh, making sure products are labeled. You talked, uh, previously about the, uh, um, labeling of things and, um- and getting a handle on what is out there. [0:42:19](https://vimeo.com/1176582204#t=2539s) But this bill would further restrict, um, some of these products out there, not all, but the synthetic, uh, um, produced products, um, out there. And, um, Catherine, would you give a committee a little more details, um, on this, uh, substitute bill? [0:42:40](https://vimeo.com/1176582204#t=2560s) Certainly happy to. Uh, good morning, committee. Um, happy to be before you to talk about hemp again today. Um, so I can, I can walk you through some of the high points of the substitute in front of you. Is that better? Um, apologies. [0:42:59](https://vimeo.com/1176582204#t=2579s) So some of the roadblocks that we've been running into when we're considering what we can and can't regulate with hemp products are our ability, and not just the departments, but all testing facilities' ability to actually test for and measure some of the cannabinoids that are, that have been mentioned. And so if, you guys may remember last year, um, one of the concerns that I had is that if we created a list of all the things that we know about, that we are essentially pushing people, market consumers, to the fringe. [0:43:37](https://vimeo.com/1176582204#t=2617s) Because what we're seeing is we're seeing the industry take synthetic cannabinoids or take other chemicals and alter them, and they're, it's like whack-a-mole. There's a new chemical that has an intoxicating effect that's being created constantly. And so if, my concern before was that if we focus on what we know about right now, we're pushing everybody out to the fringes. And so this bill takes an opposite, the opposite approach, which is it looks at the different categories that we have of cannabinoids right now, which seems to be what the, the feds are looking at and people are considering. [0:44:16](https://vimeo.com/1176582204#t=2656s) You've got your naturally occurring organic ones that occur in the plant on their own. You've got a category that occur in nature but may be, like your Delta-8 and your Delta-10, you can find those in the plants. You can also find synthetic versions of those, but they are a compound that occurs in nature. And then you go to kind of the outside, and you've got compounds like HHC that doesn't occur anywhere, um, and that you could argue is not tied to the hemp plant to begin with. [0:44:53](https://vimeo.com/1176582204#t=2693s) Um, so this bill really targets those far outliers that, and by definition, we've defined them as cannabinoids not capable of being naturally produced by the Cannabis sativa L plant. So we're, we're looking at something that has no attachment to the cannabis plant, and that is being treated like a synthetic drug. [0:45:25](https://vimeo.com/1176582204#t=2725s) So in doing so, it's listed under the restricted dangerous drugs in title, if you look on page six, in title 161371, and then it has a penalties schedule that matches what you would see in, um... This obviously can be massaged because you guys are the policy decision makers. [0:45:56](https://vimeo.com/1176582204#t=2756s) But, um, something to start with, this would be what you could find for potentially other synthetic drugs that were created for the sole purpose of having an intoxicating effect that aren't being reviewed by FDA in any capacity and, um, are just kind of on the fringes. [0:46:19](https://vimeo.com/1176582204#t=2779s) Thank you. [0:46:22](https://vimeo.com/1176582204#t=2782s) Excuse me. Um, who, who's 18? [0:46:27](https://vimeo.com/1176582204#t=2787s) Representative Carter. [0:46:28](https://vimeo.com/1176582204#t=2788s) Uh, Representative Carter. [0:46:31](https://vimeo.com/1176582204#t=2791s) Thank you. Okay. I'm just gonna be honest. Every year I learn more and more about this stuff because that's just not my world. But we trying to, I'm trying to do the best I can to support, uh, my, the businesses, the community, help people stay safe. So I'm with you with the synthetics. They've taken this stuff in the laboratory, and they created something. So with this legislation, as we look at it, and considering what, uh, the senator presented and the concern with the federal regulations, where will this version leave Georgia? [0:47:04](https://vimeo.com/1176582204#t=2824s) Certainly. So I, I will say that I, I have a slightly different perspective on, and who knows, on what might happen with the federal, um, situation. My understanding is that there are a number of efforts to push that date, uh, the effective date back beyond November. Um, there are some to completely clear it. I think if y- you can look at what Congress might do, but I think in addition to that, I don't see a world where we don't have a lawsuit and there's a stay- [0:47:33](https://vimeo.com/1176582204#t=2853s) Mm [0:47:33](https://vimeo.com/1176582204#t=2853s) ... while they work that out. Um, so I, I wouldn't be surprised, and I think it's probably, um, um, prudent to plan for there being a delay there, um, and to provide kind of a window if there is such conversation and there is an adjustment. It would make sense to, for us to be able to adopt what does go into effect- [0:47:59](https://vimeo.com/1176582204#t=2879s) Gotcha [0:47:59](https://vimeo.com/1176582204#t=2879s) ... what we actually see play out. So the substitute before you is not at all, um, triggered or impacted, um, by what's going on at the federal level. This is narrower, um, than what has, than the guidance that we have received, but not as narrow as what might be coming. [0:48:22](https://vimeo.com/1176582204#t=2902s) Gotcha. Thank you. [0:48:25](https://vimeo.com/1176582204#t=2905s) Yes, ma'am. [0:48:27](https://vimeo.com/1176582204#t=2907s) represent Camp. Uh, Chairman Camp. Thank you, Mr. Chairman. Thank you so much for being here, Katherine, and for kind of walking us through this. I was looking through the bill, and thank you for talking about adding line one twenty-six about the synthetic cannabinoids. Um, canna- can... I can't ever say the word. Cannabinoids. There we go. There we go. Um, so it looks like this would certainly enable, going back in line to ninety-one through ninety-three, enable the commissioner, the commission, um, agents, sheriff's departments, deputies, if they believe there is a product that is in violation of law, this would allow them to come and confiscate that particular thing. [0:49:09](https://vimeo.com/1176582204#t=2949s) Is that correct? Uh, yes, ma'am. But it doesn't stop the selling of hemp products throughout the state- Mm-hmm ... that are under the legal limit. That's correct. Thank you. Uh, Representative Cox. Thanks for, uh, giving us this explanation and, um, working with us in the study committee this past summer. I appreciate all that y'all offered, um, and thankful about the synthetic part, 'cause that was a, a piece that we learned a lot, I think, and very thankful for what is included. [0:49:40](https://vimeo.com/1176582204#t=2980s) Um, my question is section one dash two, and it's giving, um, lines twenty-seven down, is basically giving enforcement and how things can be done. Um, do we have any estimate on how much additional support we're needing to do this? And then what's the cost gonna be associated to fulfilling what section one point- one dash two is putting in place? [0:50:11](https://vimeo.com/1176582204#t=3011s) So a- admittedly, I did not come prepared with a number for that. Um, I will tell you that our law enforcement currently needs more s- our law enforcement division currently needs more support. So any, anything that could be offered would be, we would greatly appreciate. And, um, I'll go back to my team and see if we can come up with a more specific number for you. So there would be a fiscal note probably associated to this, I'm guessing? [0:50:39](https://vimeo.com/1176582204#t=3039s) Oh, she I, I would just I, I like to present information that's, that's, uh- I understand ... you know, based on data. All right, thank you. Representative Leverett. Thank you, Mr. Chairman. [0:51:10](https://vimeo.com/1176582204#t=3070s) Just one question. In the section where Representative Cox was referring to synthetic cannabinoid product, is that term defined somewhere in, in Title II? It, it is, um... [0:51:33](https://vimeo.com/1176582204#t=3093s) Okay, I think I'm missing a page. Synthetic cannabinoid is defined. Synthetic cannabinoid product is not. Um, and then similar question, you used that term in 1613A, and I see that there is a cross-reference back to section 2-1, which lists the synthetic cannabinoids, but that's not really a definition of synthetic cannabinoid product either. It's, you're including that as a restricted dangerous drug. [0:52:06](https://vimeo.com/1176582204#t=3126s) There's a concern that you might need to define it in here. [0:52:17](https://vimeo.com/1176582204#t=3137s) I certainly, um, that's just a well-made point. And if you would like f- um, when I have an opportunity to sit down, perhaps I'll try to draft a definition, if that's something that the chairman would be interested in. Could you repeat that a little bit? Let me make sure I understand what you're saying. It was just a little more of a, uh, legislative counsel might be able to advise whether it's necessary, but excuse me, the, the final section, or section 2-2 of the bill on page seven refers, uh, it is it illegal to possess or have in your control a synthetic cannabinoid product, but I didn't see a definition in that statute. [0:52:59](https://vimeo.com/1176582204#t=3179s) It may be elsewhere in Title II. Lines. Uh, but that was just my question. What lines are you reading? Um, I'm on page seven, uh, line one thirty-four. It starts on one thirty- four, one thirty-five, and again at one thirty-seven. That certainly makes sense. It, it- [0:53:20](https://vimeo.com/1176582204#t=3200s) That's not a definition of synthetic cannabinoid product. It cross-references to another term in the statute to define restricted dangerous drug, at least as I read that. And I don't know, for, you know, I don't really see anything about synthetics in section. All right. There's not anything. That's, um, if you're talking about 1613A, that's a new section. No, I'm talking about 2- dash 22 definition. Okay. [0:53:48](https://vimeo.com/1176582204#t=3228s) Line one twenty-six. Okay. [0:53:53](https://vimeo.com/1176582204#t=3233s) It looks like a- That- That's not a definition of synthetic cannabinoid product. It includes synthetic cannabinoids in the restricted dangerous drug. At least, technically that's included. So that was... It, it may be it's not necessary to define. Well, I think, uh, it's a well-made point that a term of art, um, that, that synthetic cannabinoid product perhaps needs to be a term of art to be listed in the dangerous drug section. I, I certainly understand, um, that perspective. I think I probably can draft something quickly. [0:54:23](https://vimeo.com/1176582204#t=3263s) Maybe I can try working with legislative counsel and present that, um, if you're interested in hearing from another, um, person- Yeah ... to give testimony? [0:54:33](https://vimeo.com/1176582204#t=3273s) Should I have something? [0:54:34](https://vimeo.com/1176582204#t=3274s) Paul. [0:54:35](https://vimeo.com/1176582204#t=3275s) Yeah. [0:54:38](https://vimeo.com/1176582204#t=3278s) Can you- [0:54:38](https://vimeo.com/1176582204#t=3278s) Okay. [0:55:00](https://vimeo.com/1176582204#t=3300s) Chairman, I'll defer to the Department of Agriculture as to the, the ultimate goal, but just drafting-wise, a very simple change would be on lines 134 to 135 to delete the word product. And again, I'm not sure if that's the intent, but instead, um, mimic the language on line 126 and just refer to synthetic cannabinoids as defined in Code Section 2-23-3. [0:55:30](https://vimeo.com/1176582204#t=3330s) So you would just include that in Section 1635? [0:55:33](https://vimeo.com/1176582204#t=3333s) Yes. [0:55:34](https://vimeo.com/1176582204#t=3334s) That, that seems like a, a good fix there. [0:55:40](https://vimeo.com/1176582204#t=3340s) Yeah. [0:55:40](https://vimeo.com/1176582204#t=3340s) I just would think somebody if they're accused in violation of the statute is gonna raise as a defense, "Well, what exactly is it? I wasn't notified what it was I was doing." [0:55:51](https://vimeo.com/1176582204#t=3351s) So my only concern with that ... I apologize. My only concern with that is if you look at line 136, paragraph 2, where we speak to the manufacturer, delivery, distribution, dispense, administer, sell, or possession with intent to distribute any synthetic cannabinoid product, if we limit that to just say synthetic cannabinoid, not the product, then y- you run into ... I don't know that manufacturer works any longer, at least not in the same sense. [0:56:22](https://vimeo.com/1176582204#t=3382s) Or, um, even deliver or distribute, because what you're essentially talking about there- [0:56:26](https://vimeo.com/1176582204#t=3386s) Yeah. [0:56:26](https://vimeo.com/1176582204#t=3386s) -is a component and not the total. [0:56:28](https://vimeo.com/1176582204#t=3388s) But- [0:56:28](https://vimeo.com/1176582204#t=3388s) Would it be a definition? [0:56:29](https://vimeo.com/1176582204#t=3389s) No, that's just- [0:56:30](https://vimeo.com/1176582204#t=3390s) Oh, okay. [0:56:31](https://vimeo.com/1176582204#t=3391s) But I, I think m- maybe an idea would be to say something like a, a definition might be synthetic cannabinoid product is a product containing in whole or in part synthetic cannabinoids as defined prior. [0:56:47](https://vimeo.com/1176582204#t=3407s) A- apologies, uh, Mr. Chairman. [0:56:49](https://vimeo.com/1176582204#t=3409s) No, I just, uh- [0:56:49](https://vimeo.com/1176582204#t=3409s) I'm talking too much. [0:56:51](https://vimeo.com/1176582204#t=3411s) I, I just love it when three attorneys are talking together. It is so over my head. I, it's, it's like, I'm not sure I've ever experienced this. [0:57:05](https://vimeo.com/1176582204#t=3425s) Well, I think- [0:57:06](https://vimeo.com/1176582204#t=3426s) Give me some here. [0:57:08](https://vimeo.com/1176582204#t=3428s) I think what she said covers that, so now you got four attorneys talking. But I like what she said. [0:57:13](https://vimeo.com/1176582204#t=3433s) Chairman? [0:57:15](https://vimeo.com/1176582204#t=3435s) Go ahead. [0:57:15](https://vimeo.com/1176582204#t=3435s) Um, sorry, Chairman, I was just getting the copy of the, the whole chapter to take a look at. Um, so the defined term hemp products, which is already in code, all products with a total Delta TH- nine THC concentration that does not exceed the le- legal limit, that are derived from or made by processing hemp plants or plant parts and that are prepared in a form available for commercial sale. I wonder if we maybe could cannibalize that. [0:57:47](https://vimeo.com/1176582204#t=3467s) Sorry, that's probably not very good wording. And, um, and so, and come up with a definit- a defined term, um, that I could stick ... 'Cause the term is also used in the new version of, of Title 23. It could stick in Title 23. It would come right after the defined term synthetic cannabinoids. So synthetic cannabinoid product, um, [0:58:18](https://vimeo.com/1176582204#t=3498s) all products containing synthetic cannabinoids. No, okay, all products that are derived from, made by, or contain, or ... [0:58:30](https://vimeo.com/1176582204#t=3510s) Do you have- [0:58:30](https://vimeo.com/1176582204#t=3510s) Do you have a copy of this in front of you? [0:58:32](https://vimeo.com/1176582204#t=3512s) I don't. Um, I don't think- [0:58:34](https://vimeo.com/1176582204#t=3514s) By processing, um, synthetic cannabinoids and that are prepared in a form available for commercial sale, so similar to that defined term, but instead using, referring back to the defined term that's already in there, synthetic cannabinoids. [0:58:51](https://vimeo.com/1176582204#t=3531s) I think, I think so. I think we can take out all the verbs except containing. [0:58:56](https://vimeo.com/1176582204#t=3536s) Okay, so [0:59:01](https://vimeo.com/1176582204#t=3541s) products. [0:59:02](https://vimeo.com/1176582204#t=3542s) Containing products. Containing. [0:59:05](https://vimeo.com/1176582204#t=3545s) So, okay, so all products containing synthetic cannabinoids. [0:59:12](https://vimeo.com/1176582204#t=3552s) Let's, can we say in whole or in part? [0:59:15](https://vimeo.com/1176582204#t=3555s) So- [0:59:16](https://vimeo.com/1176582204#t=3556s) So if we had like a, um ... Yeah. [0:59:19](https://vimeo.com/1176582204#t=3559s) Well, have lunch. [0:59:23](https://vimeo.com/1176582204#t=3563s) Okay. [0:59:24](https://vimeo.com/1176582204#t=3564s) I was trying to sit down, y'all. [0:59:27](https://vimeo.com/1176582204#t=3567s) Containing in whole or in part. [0:59:32](https://vimeo.com/1176582204#t=3572s) Okay. [0:59:38](https://vimeo.com/1176582204#t=3578s) Chairman Leverett, are we, think we're good? [0:59:42](https://vimeo.com/1176582204#t=3582s) We're satisfied. [0:59:44](https://vimeo.com/1176582204#t=3584s) Chairman, when the time comes, I can state my- [0:59:46](https://vimeo.com/1176582204#t=3586s) Okay. We'll, we'll do that when the time comes. Okay, uh, got a couple more questions and then maybe we'll, uh, move on. Uh, Chairman, um, Corbett. [0:59:56](https://vimeo.com/1176582204#t=3596s) Thank you, Mr. Chairman. Thank you, uh, Catherine. We was talk- a question come up earlier about increased cost or whatever to do what's in this bill. Uh, and I know when we first started out, we only, uh, licensed for the, for growers and processors and we, we didn't generate enough funds to even think about sustaining the, the program, what we're generating. But we expanded that base a couple years ago to the, the, the processors, the growers, the retailers, and the wholesalers. And since doing that, there's quite a bit more revenue coming in to, to, to take care of, uh, the, the hemp program. [1:00:29](https://vimeo.com/1176582204#t=3629s) Does that money go to the general fund and we have to appropriate that back? Is that the way that's works now? [1:00:33](https://vimeo.com/1176582204#t=3633s) It, it goes to the general fund. [1:00:35](https://vimeo.com/1176582204#t=3635s) That's right, and we're generating a lot, lot more money. So m- we're generating the money to do it, we just gotta appropriate it back, if I understand that right. [1:00:40](https://vimeo.com/1176582204#t=3640s) I think we, I think that the fees this year generated over a million dollars. [1:00:44](https://vimeo.com/1176582204#t=3644s) Uh, different. [1:00:45](https://vimeo.com/1176582204#t=3645s) 2.2. [1:00:46](https://vimeo.com/1176582204#t=3646s) So, so, so I, I, I- [1:00:47](https://vimeo.com/1176582204#t=3647s) 2 million. [1:00:47](https://vimeo.com/1176582204#t=3647s) It's just up to us to appropriate it back? [1:00:50](https://vimeo.com/1176582204#t=3650s) That'd be lovely. [1:00:52](https://vimeo.com/1176582204#t=3652s) Slater's just- [1:00:53](https://vimeo.com/1176582204#t=3653s) Yeah. [1:00:56](https://vimeo.com/1176582204#t=3656s) She appreciates you all. Representative O'Steen. [1:00:59](https://vimeo.com/1176582204#t=3659s) Thank you, Mr. Chairman. Kathryn, you know I asked that question earlier about distinguishing the difference in the, in the, in the vapes. Does line 60 through [1:01:11](https://vimeo.com/1176582204#t=3671s) 64 address that? [1:01:17](https://vimeo.com/1176582204#t=3677s) So I, I listened to the discussion surrounding your question, and I, I am, wasn't sure I followed some of, some of the back and forth. Could, could you, could you ask me the question again, as you intended? [1:01:32](https://vimeo.com/1176582204#t=3692s) How can I differentiate between a nicotine vape and a vape containing this product? [1:01:40](https://vimeo.com/1176582204#t=3700s) When you're purchasing, or a person- [1:01:40](https://vimeo.com/1176582204#t=3700s) When I'm purchasing, when it's on my person, if, if law enforcement is trying to distinguish, how do they distinguish? [1:01:47](https://vimeo.com/1176582204#t=3707s) So there are, there are requirements when you purchase in store, um, for, for hemp products. It'll have the THC triangle with the marijuana leaf displaying it. There are requirements. The vapes have to meet every labeling requirement that all of the other hemp products do as well. So they'll have a COA, um, that you can find by, by scanning the QR code. It will tell you, um, what the test results are for all of the testing requirements that the department lays out. [1:02:17](https://vimeo.com/1176582204#t=3737s) Um, and [1:02:21](https://vimeo.com/1176582204#t=3741s) now, now that's, that's the container when purchased. Um, if you were to walk past someone on the street, if y- I, I don't know that you would necessarily be able- [1:02:37](https://vimeo.com/1176582204#t=3757s) I see [1:02:37](https://vimeo.com/1176582204#t=3757s) ... to tell if it's nicotine, or if it's hemp, or if it's low THC oil- [1:02:42](https://vimeo.com/1176582204#t=3762s) Some cannabis [1:02:42](https://vimeo.com/1176582204#t=3762s) ... which I think we heard on the floor is, um, odorless. So, um, I do think that, that n- no vapes at this time, that I'm aware of, and I'm not an expert in this, but, or have any kind of labeling for onlookers to know. [1:03:00](https://vimeo.com/1176582204#t=3780s) Okay. Thank you so much. [1:03:02](https://vimeo.com/1176582204#t=3782s) Uh, Representative Dawson. [1:03:07](https://vimeo.com/1176582204#t=3787s) Thank you. Thank you, Mr. Chair. Had a quick question regarding the concentration. Like on line three, we say the second point that we're providing for limits on the total THC concentration in consumable hemp products, in the first bill we were talking about that .3% concentration, but I don't see that here. It looks like we're moving on, on line 146 to discuss concentration in terms of aggre- aggregate weight. [1:03:38](https://vimeo.com/1176582204#t=3818s) Is that what happened between the two bills? We switched from the .3 concentration to now we're having this d- discussion about aggregate weight of any m- mixtures. Just some clarification there. Thank you. [1:03:53](https://vimeo.com/1176582204#t=3833s) So the measurement in the initial bill, the underlying bill, um, the .3% THC measured on a dry weight basis is the standard with which we are currently measuring Delta-9 THC. And the concept for the underlying bill is that you would aggregate all forms of THC, and that cumulatively, those could not exceed .3%. [1:04:23](https://vimeo.com/1176582204#t=3863s) And that, so that speaks to how intoxicating a hemp product would be. On line 146, um, what we're look... This is, um, this is speaking to the penalties. If you were to... They're, they're tiered penalties based on, um, as with any other drug, on the amount that you're carrying, moving, moving, manufacturing, trafficking. [1:04:49](https://vimeo.com/1176582204#t=3889s) So, so where do we discuss the, where do we provide limits on the total C, THC concentration in this bill? [1:04:58](https://vimeo.com/1176582204#t=3898s) There is not one. [1:05:00](https://vimeo.com/1176582204#t=3900s) Okay. [1:05:00](https://vimeo.com/1176582204#t=3900s) So this bill leaves the Delta-9 threshold where it is, and then instead of adding to that fr- looking at different buckets of cannabinoids, it just says, "This whole bucket is out- [1:05:16](https://vimeo.com/1176582204#t=3916s) Okay [1:05:16](https://vimeo.com/1176582204#t=3916s) ... 'cause we aren't sure what that is." [1:05:18](https://vimeo.com/1176582204#t=3918s) So do we need to strike the tail end of line three and the beginning of line four, or not necessary? [1:05:27](https://vimeo.com/1176582204#t=3927s) Where we're saying that we're providing for limits on the total THC concentration in consumable hemp products. [1:05:34](https://vimeo.com/1176582204#t=3934s) So I believe that summary, um, at the, the beginning here is likely, um, just held over and can probably be, um, edited. Is, that's, that doesn't technically fall in part of code. Is that right, Paul? [1:05:49](https://vimeo.com/1176582204#t=3949s) I'm sorry, what lines? [1:05:50](https://vimeo.com/1176582204#t=3950s) Uh, three and four at the beginning. [1:05:52](https://vimeo.com/1176582204#t=3952s) So that's the title. [1:05:53](https://vimeo.com/1176582204#t=3953s) That's not codified. Correct. [1:05:54](https://vimeo.com/1176582204#t=3954s) Right. So that can be amended. Oftentimes I think those don't quite get updated as quickly as bills change. [1:06:01](https://vimeo.com/1176582204#t=3961s) Okay. [1:06:01](https://vimeo.com/1176582204#t=3961s) Thanks. Thank you. [1:06:02](https://vimeo.com/1176582204#t=3962s) All right. We're getting, uh, close to, um, 12:00. Uh, y- you good, Jordain? I'm with. Okay. Um, anybody, who else got some real- [1:06:13](https://vimeo.com/1176582204#t=3973s) Well, I- [1:06:13](https://vimeo.com/1176582204#t=3973s) ... questions? You got a- [1:06:14](https://vimeo.com/1176582204#t=3974s) I do. [1:06:15](https://vimeo.com/1176582204#t=3975s) Okay. [1:06:15](https://vimeo.com/1176582204#t=3975s) I'll take 20 seconds, Mr. Chairman. [1:06:17](https://vimeo.com/1176582204#t=3977s) Um, [1:06:20](https://vimeo.com/1176582204#t=3980s) uh, you five? Number four. [1:06:22](https://vimeo.com/1176582204#t=3982s) Yeah. [1:06:22](https://vimeo.com/1176582204#t=3982s) Four. Uh, four. [1:06:23](https://vimeo.com/1176582204#t=3983s) Yes, sir. Thank you, Mr. Chairman. A- a- and thank you. I'm always amazed with your brilliance. You are just so smart, and you represent the department so well. Two points of clarity for me. [1:06:32](https://vimeo.com/1176582204#t=3992s) She should get a raise. [1:06:33](https://vimeo.com/1176582204#t=3993s) Uh, right, she should get a raise. Uh, let's, let's, let- let's get a fiscal note on that. But, um, number one, this bill here is a department bill, right? This is supported by the department? [1:06:46](https://vimeo.com/1176582204#t=4006s) The, um, the department supports this bill. [1:06:49](https://vimeo.com/1176582204#t=4009s) Department. Same to me. Okay. Number two [1:06:52](https://vimeo.com/1176582204#t=4012s) this is not putting the cart before the horse as it relates to the federal policy that we're waiting to see what's gonna happen, and which you just raised a very important point. There can be stays. There can be so many things that can happen. But this is, th- this bill allows us to move forward with enforcement and not put the cart before the horse, correct? [1:07:10](https://vimeo.com/1176582204#t=4030s) I believe that to be the intention- [1:07:11](https://vimeo.com/1176582204#t=4031s) Okay [1:07:12](https://vimeo.com/1176582204#t=4032s) ... and, and the result of the bill [1:07:13](https://vimeo.com/1176582204#t=4033s) ... and with that, that's why I, I support this bill, Mr. Chairman. At an appropriate time, I'd like to move it. [1:07:17](https://vimeo.com/1176582204#t=4037s) Thank you. Um, Chairman Meeks. [1:07:21](https://vimeo.com/1176582204#t=4041s) Thank you, Mr. Chairman, um, and thanks for your work, and Catherine, uh, on this bill to really, uh, narrowly tailor what we're trying to take off the market, and that is those products that are not regulated, uh, that are 100%, uh, synthetic, um, and that we really don't know what it is that the consumers are getting. Um, so Mr. Chairman, with that, uh, I would move due pass, uh, Senate Bill 33, LC443559S. [1:07:51](https://vimeo.com/1176582204#t=4071s) I'll second, since I said appropriate, he took it. I was [1:07:56](https://vimeo.com/1176582204#t=4076s) Hi- his thing's been flashing a lot longer than yours. Okay. We, um, we have a motion and a second, um, on, um, LC443559S, and, um, we have, um, an amendment to, to that. Um, do I need a motion for the amendment? I need a motion for the amendment. [1:08:23](https://vimeo.com/1176582204#t=4103s) It's like anytime. [1:08:24](https://vimeo.com/1176582204#t=4104s) Got a motion, got a second. [1:08:25](https://vimeo.com/1176582204#t=4105s) We'll handle to read it out. [1:08:27](https://vimeo.com/1176582204#t=4107s) Uh, so I've, I've, uh, let counsel, uh, to r- read out the amendment. [1:08:32](https://vimeo.com/1176582204#t=4112s) Yes, Chairman. The amendment would consist of after line 23- [1:08:43](https://vimeo.com/1176582204#t=4123s) ... adding a new paragraph 26.2, "Synthetic cannabinoid product means all products containing synthetic cannabinoids in whole or in part, and that are prepared in a form available for commercial sale." [1:09:08](https://vimeo.com/1176582204#t=4148s) The second [1:09:11](https://vimeo.com/1176582204#t=4151s) change would be [1:09:19](https://vimeo.com/1176582204#t=4159s) lines 134 and 135- [1:09:26](https://vimeo.com/1176582204#t=4166s) Yeah [1:09:26](https://vimeo.com/1176582204#t=4166s) ... uh, to change it to read, "Any synthetic cannabinoid product [1:09:34](https://vimeo.com/1176582204#t=4174s) as defined in," I just had it, "code section 2-23-3," and then make the same change on line 37, "Any synthetic cannabinoid product as defined in code section 2-23-3," and then to make any required conforming non-substantive changes to the rest of the bill. [1:10:02](https://vimeo.com/1176582204#t=4202s) Thank you, Paul. Uh, did everybody understand that? [1:10:06](https://vimeo.com/1176582204#t=4206s) Yeah. [1:10:06](https://vimeo.com/1176582204#t=4206s) Okay. I trust my attorneys. [1:10:10](https://vimeo.com/1176582204#t=4210s) You're welcome. [1:10:11](https://vimeo.com/1176582204#t=4211s) All right, so we need a, we got a motion to second on, on those, um, amendments, uh, to the bill. Um, any other questions about those amendments? [1:10:20](https://vimeo.com/1176582204#t=4220s) I, I- [1:10:20](https://vimeo.com/1176582204#t=4220s) I mean, the corrections amendments. Yeah. [1:10:23](https://vimeo.com/1176582204#t=4223s) I, I, I have a question- [1:10:24](https://vimeo.com/1176582204#t=4224s) Yeah [1:10:24](https://vimeo.com/1176582204#t=4224s) ... to the amendment. I thought my question was gonna be to the bill, but it's to the amendment, 'cause here's my concern. We just wiped out all synthetics, so we're saying that all synthetics are harmful, and it's not gonna affect any of these folk that's been texting and emailing us. [1:10:39](https://vimeo.com/1176582204#t=4239s) Yes. [1:10:40](https://vimeo.com/1176582204#t=4240s) 'Cause we just, we're wiping out all synthetics. [1:10:43](https://vimeo.com/1176582204#t=4243s) All synthetics. [1:10:43](https://vimeo.com/1176582204#t=4243s) All of them. [1:10:46](https://vimeo.com/1176582204#t=4246s) Yes. [1:10:47](https://vimeo.com/1176582204#t=4247s) If it didn't arrive from a hemp plant, that's, I think, uh ... We, we got a definition in here, don't we, c- uh, Catherine, of synthetics? [1:10:56](https://vimeo.com/1176582204#t=4256s) Sorry. I'm just concerned about the folk, like we were talking earlier ab- about, there are some people that have, they're in the industry, they have got business, and some of these ... I, I don't use the stuff, so I don't know, but some synthetics, I don't know if some synthetics are not dangerous or we- but we're saying all synthetics, and I just want the folk to understand what we're doing here. Yes, ma'am. Okay. So I, I, what's complicated about referencing synthetics is that people say the same word and mean different things. [1:11:28](https://vimeo.com/1176582204#t=4288s) Mm-hmm. So for this bill, we are not including cannabinoids that are, that you use some ki- some kind of process to, to extract. We're not including those. [1:11:41](https://vimeo.com/1176582204#t=4301s) Okay. [1:11:41](https://vimeo.com/1176582204#t=4301s) We are not including, um, products, or we are not in- including, like, your delta, your delta-8 THC, which occurs in nature. You can also create that through a synthetic process. We are not addressing those. The majority of products that you see in stores will fall into that category. The category that we are addressing are synthetic chemicals that do not occur in nature and are in no way associated with the hemp plant. [1:12:21](https://vimeo.com/1176582204#t=4341s) So- [1:12:21](https://vimeo.com/1176582204#t=4341s) We're trying to get this back to a hemp-based- [1:12:24](https://vimeo.com/1176582204#t=4344s) No, I got you [1:12:24](https://vimeo.com/1176582204#t=4344s) ... material. That was the intent. [1:12:26](https://vimeo.com/1176582204#t=4346s) No, no, I got you. [1:12:26](https://vimeo.com/1176582204#t=4346s) A lot of people- [1:12:28](https://vimeo.com/1176582204#t=4348s) And so- [1:12:28](https://vimeo.com/1176582204#t=4348s) ... did this- [1:12:29](https://vimeo.com/1176582204#t=4349s) Some, some- She's helping me. I'm sorry. No, you're helping me. I just want to make sure that that definition that you just used is what- Well, well- ... that we're clear that's what we're doing ... let's, let's read it and- Okay ... let's, let's make sure that I, I want this to be what the committee, committee would like. Um, so the definition on line 22 reads [1:12:55](https://vimeo.com/1176582204#t=4375s) synthetic cannabinoid in this section means a cannabinoid that is not capable of being naturally produced by the Cannabis sativa L plant, which is the common reference for cannabis plants. Okay. [1:13:13](https://vimeo.com/1176582204#t=4393s) Okay. [1:13:14](https://vimeo.com/1176582204#t=4394s) Okay. So we got a motion and a second for the, um, substitute to the substitute to the corrections file. I need a vote on that. Any other questions about that? All in favor say aye. Aye. To the m- to the amendment to the amendment, I mean, to the- ... committee sub. Amendment to the committee sub, um, thank you. Aye. Aye. All opposed. Okay, that, um, passes. So now the question, uh, to the committee is for LC 443559 S committee sub to SB 33. [1:13:53](https://vimeo.com/1176582204#t=4433s) As amended. [1:13:54](https://vimeo.com/1176582204#t=4434s) As amended. Thank you. Any, any other discussion or questions from the committee? [1:14:06](https://vimeo.com/1176582204#t=4446s) Mr. Chairman, uh, Representative- [1:14:08](https://vimeo.com/1176582204#t=4448s) Thank you for acknowledging me, Mr. Chairman, but I just want to be absolutely clear, back to what Representative Carter stated. All these emails we received, the families that I talked to last night that shared with me how the previous bill would hurt their quality of life. Are we, this bill is gonna do, what we're about to do now is gonna do the exact same thing? No. It's gonna be... Okay. All right. [1:14:31](https://vimeo.com/1176582204#t=4471s) All right. [1:14:32](https://vimeo.com/1176582204#t=4472s) Very good. Just wanna make sure. Thank you. [1:14:34](https://vimeo.com/1176582204#t=4474s) Representative Dunahoo. [1:14:37](https://vimeo.com/1176582204#t=4477s) Thank you, Mr. Chairman. I just wanna ask one simple question. Basically, the previous bill, terrible, okay? And I've been reading both of them nonstop, so it's a little confusing. The short bill is a, a lot more common sense. We're trying to lay a foundation here for the State of Georgia to pass something that will stand up with the federal government comes through with theirs. Is that true or false? [1:15:06](https://vimeo.com/1176582204#t=4506s) And will this give the commissioner more authority if needed? [1:15:13](https://vimeo.com/1176582204#t=4513s) I hate to, to answer your first question with a maybe. Um, th- that is kind of, um, it kind of depends on what the feds do. Um, but, um, what I, what I would say is that in talking with- [1:15:28](https://vimeo.com/1176582204#t=4528s) This is Reese [1:15:29](https://vimeo.com/1176582204#t=4529s) ... with people involved in the space, there does not, there appears to be a consensus in controlling what chemicals and compounds people are putting in their bodies. [1:15:41](https://vimeo.com/1176582204#t=4541s) Right. [1:15:41](https://vimeo.com/1176582204#t=4541s) And it appears that while some people, um, may have different opinions about synthetics for, that are, that are, can naturally occur, you know, you, you can make the argument that that's similar to Epidiolex, like that's a pharmaceutical drug that's synthetic, but we prescribe it. Y- so there's some differing opinions there, but I haven't heard anyone say that we really need to protect this kind of runaway train of evolving chemicals. [1:16:15](https://vimeo.com/1176582204#t=4575s) And so I, it, this a- a- appears to, to me to be, um... We do try to stay neutral. I, I know it doesn't appear that way, but we, we do try to stay neutral and, and help people come to, to a similar, um, w- where, where like minds come together. And, and this seems to be something that, that g- we can support, we can enforce, and that, that people would like. [1:16:38](https://vimeo.com/1176582204#t=4598s) Thank you. [1:16:39](https://vimeo.com/1176582204#t=4599s) Representative Willis, have you got any comment? [1:16:41](https://vimeo.com/1176582204#t=4601s) I do, and I'll be brief, Mr. Chairman, 'cause I know you're sick of me, but thank you so much. Um, I would like to just go on record for clarification for you, too, Rep Stinson. The issues that we've been hearing about for 2,013 emails were about this bill. This one, the first one that we discussed. This substitute, and I'm just, please correct me and clarify for me, this substitute does not, um, this substitute focuses on synthetics that cannot be naturally produced by the plant. [1:17:12](https://vimeo.com/1176582204#t=4632s) Okay? Um, as, and, and does not hinder cannabinoids that can naturally be produced by the plant. There's still a certificate of authenticity, I'm sorry, c- excuse me, certificate of analysis involved that people have to have to show what is in the products that they are selling, and those COAs can be scanned, like you said, and you can see what's in it. This focuses on synthetics and creating a framework around a regulatory pattern upon evolving synthetics. [1:17:45](https://vimeo.com/1176582204#t=4665s) Is that, is that appropriate in plain speak? [1:17:47](https://vimeo.com/1176582204#t=4667s) Yes, ma'am. [1:17:48](https://vimeo.com/1176582204#t=4668s) Okay. Thank you. [1:17:49](https://vimeo.com/1176582204#t=4669s) Thank, thank you, Representative Willis. You're good, ma'am. [1:17:52](https://vimeo.com/1176582204#t=4672s) Yeah, we good. [1:17:52](https://vimeo.com/1176582204#t=4672s) Representative Cannon. Call the question, Mr. Chairman. Thank you. So we're, uh, to the question. Which question? All in favor of, uh, substitute to SB 33, uh, uh, 443559S signify by s- [1:18:12](https://vimeo.com/1176582204#t=4692s) As amended. [1:18:12](https://vimeo.com/1176582204#t=4692s) Huh? As amended. Thank you. Uh, signify, signify by saying aye. Aye. Opposed. Unanimous. Thank you, committee. Uh, John, we got, uh, lunch? [1:18:25](https://vimeo.com/1176582204#t=4705s) We, we, we've got lunch, the Rural Caucus down in the Ag Building. Just a reminder. [1:18:29](https://vimeo.com/1176582204#t=4709s) Thank you, and, uh, have a great Ag Week this week. [1:18:46](https://vimeo.com/1176582204#t=4726s) Right.